CBLN1
Cerebellin-1
Also known as: CBLN1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P23435
- Gene
- CBLN1
- Ensembl
- ENSG00000102924
- Chromosome
- 16
- Canonical length
- 193 aa
- Protein class
- Predicted secreted proteins
- Subcellular location
- Cytosol,Perinuclear theca,Calyx,Flagellar centriole,Mid piece,Principal piece
- Secretome location
- Secreted in brain
- Quaternary structure
- Homohexamer
OverviewNCBI Gene
This gene encodes a cerebellum-specific precursor protein, precerebellin, with similarity to the globular (non-collagen-like) domain of complement component C1qB. Precerebellin is processed to give rise to several derivatives, including the hexadecapeptide, cerebellin, which is highly enriched in postsynaptic structures of Purkinje cells. Cerebellin has also been found in human and rat adrenals, where it has been shown to enhance the secretory activity of this gland. [provided by RefSeq, Aug 2008]
Canonical amino-acid sequenceUniProt
193 residues, UniProt reviewed canonical sequence.
>P23435|CBLN1
1 MLGVLELLLL GAAWLAGPAR GQNETEPIVL EGKCLVVCDS NPTSDPTGTA LGISVRSGSA
61 KVAFSAIRST NHEPSEMSNR TMIIYFDQVL VNIGNNFDSE RSTFIAPRKG IYSFNFHVVK
121 VYNRQTIQVS LMLNGWPVIS AFAGDQDVTR EAASNGVLIQ MEKGDRAYLK LERGNLMGGW
181 KYSTFSGFLV FPLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CBLN1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 425 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 425 nTPM
- hypothalamus: 34 nTPM
- testis: 30 nTPM
- midbrain: 17 nTPM
- adipose tissue: 11 nTPM
- spinal cord: 9.1 nTPM
Single-cell type
- late spermatids: 523 nCPM
- late primary spermatocytes: 153 nCPM
- early spermatids: 86 nCPM
- brain excitatory neurons: 64 nCPM
- vascular smooth muscle cells: 18 nCPM
- early primary spermatocytes: 13 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 239 nTPM
- hypothalamus: 54 nTPM
- midbrain: 37 nTPM
- pons: 27 nTPM
- thalamus: 26 nTPM
- medulla oblongata: 22 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.98
- gnomAD pLI
- 0.18
- gnomAD missense Z
- 1.68
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cerebellar granule cell differentiation
- chemical synaptic transmission
- establishment of localization in cell
- heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules
- maintenance of synapse structure
- negative regulation of excitatory postsynaptic potential
- nervous system development
- positive regulation of long-term synaptic depression
- positive regulation of synapse assembly
- protein secretion
- regulation of postsynaptic density assembly
- regulation of presynapse assembly
- synapse assembly
- synapse organization
- trans-synaptic signaling, modulating synaptic transmission
- negative regulation of inhibitory synapse assembly
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CBLN1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CBLN1 as an antibody target. Whether an autoantibody or antibody against CBLN1 could matter depends on whether native CBLN1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CBLN1 is annotated at the cell surface, where native CBLN1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CBLN1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...